Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CpG Oligonucleotides as Vaccine Adjuvants
Neslihan Kayraklioglu, Begum Horuluoglu, Dennis M. Klinman
Methods in molecular biology (2020), pp. 51-85
Closed Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 89
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 85
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 24
Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development
Gaurav Sinsinbar, Anivind Kaur Bindra, Shaoqiong Liu, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 541-563
Closed Access | Times Cited: 17
Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics
Juergen Scharner, Isabel Aznarez
Molecular Therapy (2020) Vol. 29, Iss. 2, pp. 540-554
Open Access | Times Cited: 73
A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy
Liming Zhang, Lingfeng Xu, Yi Wang, et al.
Chinese Chemical Letters (2022) Vol. 33, Iss. 8, pp. 4089-4095
Closed Access | Times Cited: 65
Challenges in the Vaccination of the Elderly and Strategies for Improvement
Gatot Soegiarto, Dewajani Purnomosari
Pathophysiology (2023) Vol. 30, Iss. 2, pp. 155-173
Open Access | Times Cited: 31
Understanding nucleic acid sensing and its therapeutic applications
Ling-Zu Kong, Seok‐min Kim, Chunli Wang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2320-2331
Open Access | Times Cited: 29
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 16
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery
İlayda Baydemir, Elisabeth A. Dulfer, Mihai G. Netea, et al.
Clinical Immunology (2024) Vol. 261, pp. 109930-109930
Open Access | Times Cited: 9
Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
Zhou Yan, Ting Zhang, Zhirong Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
Jinkai Zang, Yuanfei Zhu, Yu Zhou, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Jeroen Pollet, Ulrich Strych, Wen‐Hsiang Chen, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3655-3663
Open Access | Times Cited: 37
Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
Yang Yang, Hongyi Li, Christina Fotopoulou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
β-Glucan—A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects
Liuyang He, Zhichao Zhu, Chunjian Qi
Carbohydrate Polymers (2024) Vol. 339, pp. 122252-122252
Closed Access | Times Cited: 8
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy
Jie Zheng, Mingshuang Wang, Liwei Pang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 568-582
Closed Access | Times Cited: 7
The important role of non‐covalent drug‐protein interactions in drug hypersensitivity reactions
Werner J. Pichler
Allergy (2021) Vol. 77, Iss. 2, pp. 404-415
Open Access | Times Cited: 39
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
Noémi Nagy, Aram de Haas, Teunis B. H. Geijtenbeek, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Recent Developments in Nanoparticle‐Based Photo‐Immunotherapy for Cancer Treatment
Zhongyuan Guo, Audrey T. Zhu, Ronnie H. Fang, et al.
Small Methods (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 14
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters
Hung‐Chun Liao, Kuan‐Yin Shen, Chung‐Hsiang Yang, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 32, Iss. 1, pp. 101169-101169
Open Access | Times Cited: 13
Macrophage-targeted nanoparticles mediate synergistic photodynamic therapy and immunotherapy of tuberculosis
Na Tian, Huijuan Duan, Tingming Cao, et al.
RSC Advances (2023) Vol. 13, Iss. 3, pp. 1727-1737
Open Access | Times Cited: 12
A Multi‐Functional Nanoadjuvant Coupling Manganese with Toll‐Like 9 Agonist Stimulates Potent Innate and Adaptive Anti‐Tumor Immunity
Zhongjie Liu, Shu Li, Yang Xiao, et al.
Advanced Science (2024) Vol. 11, Iss. 41
Open Access | Times Cited: 4
Pulmonary Delivery of Nonviral Nucleic Acid‐Based Vaccines With Spotlight on Gold Nanoparticles
Carolina Araujo Cirne, Marianna Földvári
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Open Access
Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top